Cijena dionica i vijesti za Iovance Biotherapeutics Inc (2LB) – Google Finance

Financije

Početna stranica2LB • FRA

Iovance Biotherapeutics Inc

3,21 €

17. tra, 22:56:33 GMT+2 · EUR · FRA · Odricanje od odgovornosti

VrijednosnicaZemlja u kojoj se trguje vrijednosnicom: DEZemlja u kojoj se nalazi sjedište: SAD

Preth. zaklj. cijena

3,22 €

Dnevni raspon

3,21 € - 3,21 €

Godišnji raspon

1,43 € - 4,74 €

Tržišna kapitalizacija

1,59 mlr. USD

Prosječna količina

1,19 tis.

P/E omjer

-

Prinos dividende

-

Glavno tržište vrijednosnica

NASDAQ

Vijesti s tržišta

US Stock Market Week Ahead: Record S&P 500 Rally Faces Iran Risk, Tesla Earnings and Fed Hearing

Big Tech’s $4 Trillion Boomerang Powers S&P 500 to New Heights

Assessing Galaxy Digital (NasdaqGS:GLXY) Valuation After SEC Crypto Task Force Tokenization Filing

Berkshire shares left behind as S&P 500 rallies to record high

Investor's Business Daily

Dow Jones Futures, Oil Prices Loom; Trump Announces New Iran Talks With Hormuz Shut

Should You Buy the Vanguard S&P 500 ETF With the Stock Market At a Fresh Record High? The Answer Might Surprise You.

Više

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia

Osnovano

2007

Sjedište

San Carlos, Kalifornija
Sjedinjene Američke Države

Web-lokacija

Zaposlenici

975

Pretraživanje

Izbriši pretraživanje

Zatvaranje pretraživanja

Googleove aplikacije

Glavni izbornik